<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-01-31" version="215">
<accession>P00488</accession>
<accession>Q59HA7</accession>
<accession>Q8N6X2</accession>
<accession>Q96P24</accession>
<accession>Q9BX29</accession>
<name>F13A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Coagulation factor XIII A chain</fullName>
<shortName>Coagulation factor XIIIa</shortName>
<ecNumber evidence="18">2.3.2.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein-glutamine gamma-glutamyltransferase A chain</fullName>
</alternativeName>
<alternativeName>
<fullName>Transglutaminase A chain</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">F13A1</name>
<name type="synonym">F13A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Biochemistry" volume="25" first="6900" last="6906">
<title>Amino acid sequence of the a subunit of human factor XIII.</title>
<authorList>
<person name="Ichinose A."/>
<person name="Hendrickson L.E."/>
<person name="Fujikawa K."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="3026437"/>
<dbReference type="DOI" id="10.1021/bi00370a025"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ILE-651</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="8024" last="8028">
<title>Characterization of cDNA coding for human factor XIIIa.</title>
<authorList>
<person name="Grundmann U."/>
<person name="Amann E."/>
<person name="Zettlmeissl G."/>
<person name="Kuepper H.A."/>
</authorList>
<dbReference type="PubMed" id="2877457"/>
<dbReference type="DOI" id="10.1073/pnas.83.21.8024"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="5829" last="5833">
<title>Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor.</title>
<authorList>
<person name="Ichinose A."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="2901091"/>
<dbReference type="DOI" id="10.1073/pnas.85.16.5829"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LEU-565</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT GLU-652</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2001-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LEU-35; ILE-40; PHE-205; LEU-565; ILE-651 AND GLU-652</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT GLU-652</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ILE-650 AND GLU-652</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="8019" last="8023">
<title>Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.</title>
<authorList>
<person name="Takahashi N."/>
<person name="Takahashi Y."/>
<person name="Putnam F.W."/>
</authorList>
<dbReference type="PubMed" id="2877456"/>
<dbReference type="DOI" id="10.1073/pnas.83.21.8019"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-731</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1974" name="Biochemistry" volume="13" first="750" last="756">
<title>Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.</title>
<authorList>
<person name="Takagi T."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="4811064"/>
<dbReference type="DOI" id="10.1021/bi00701a018"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-44</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1973" name="J. Biol. Chem." volume="248" first="1395" last="1407">
<title>Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.</title>
<authorList>
<person name="Schwartz M.L."/>
<person name="Pizzo S.V."/>
<person name="Hill R.L."/>
<person name="McKee P.A."/>
</authorList>
<dbReference type="PubMed" id="4405643"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-614</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="Physiol. Rev." volume="91" first="931" last="972">
<title>Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.</title>
<authorList>
<person name="Muszbek L."/>
<person name="Bereczky Z."/>
<person name="Bagoly Z."/>
<person name="Komaromi I."/>
<person name="Katona E."/>
</authorList>
<dbReference type="PubMed" id="21742792"/>
<dbReference type="DOI" id="10.1152/physrev.00016.2010"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Mol. Genet. Genomic Med." volume="3" first="258" last="271">
<title>Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants.</title>
<authorList>
<person name="Thomas A."/>
<person name="Biswas A."/>
<person name="Ivaskevicius V."/>
<person name="Oldenburg J."/>
</authorList>
<dbReference type="PubMed" id="26247044"/>
<dbReference type="DOI" id="10.1002/mgg3.138"/>
</citation>
<scope>INTERACTION WITH F13B</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="7296" last="7300">
<title>Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.</title>
<authorList>
<person name="Yee V.C."/>
<person name="Pedersen L.C."/>
<person name="Trong I.L."/>
<person name="Bishop P.D."/>
<person name="Stenkamp R.E."/>
<person name="Teller D.C."/>
</authorList>
<dbReference type="PubMed" id="7913750"/>
<dbReference type="DOI" id="10.1073/pnas.91.15.7296"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS)</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Thromb. Res." volume="78" first="389" last="397">
<title>Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.</title>
<authorList>
<person name="Yee V.C."/>
<person name="Pedersen L.C."/>
<person name="Bishop P.D."/>
<person name="Stenkamp R.E."/>
<person name="Teller D.C."/>
</authorList>
<dbReference type="PubMed" id="7660355"/>
<dbReference type="DOI" id="10.1016/0049-3848(95)00072-Y"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS)</scope>
<scope>CALCIUM-BINDING</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="FEBS Lett." volume="423" first="291" last="296">
<title>Two non-proline cis peptide bonds may be important for factor XIII function.</title>
<authorList>
<person name="Weiss M.S."/>
<person name="Metzner H.J."/>
<person name="Hilgenfeld R."/>
</authorList>
<dbReference type="PubMed" id="9515726"/>
<dbReference type="DOI" id="10.1016/S0014-5793(98)00098-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="4917" last="4923">
<title>Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography.</title>
<authorList>
<person name="Fox B.A."/>
<person name="Yee V.C."/>
<person name="Pedersen L.C."/>
<person name="le Trong I."/>
<person name="Bishop P.D."/>
<person name="Stenkamp R.E."/>
<person name="Teller D.C."/>
</authorList>
<dbReference type="PubMed" id="9988734"/>
<dbReference type="DOI" id="10.1074/jbc.274.8.4917"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1994" name="Hum. Genet." volume="94" first="129" last="135">
<title>Molecular basis for subtypic differences of the 'a' subunit of coagulation factor XIII with description of the genesis of the subtypes.</title>
<authorList>
<person name="Suzuki K."/>
<person name="Iwata M."/>
<person name="Ito S."/>
<person name="Matsui K."/>
<person name="Uchida A."/>
<person name="Mizoi Y."/>
</authorList>
<dbReference type="PubMed" id="7913909"/>
<dbReference type="DOI" id="10.1007/BF00202857"/>
</citation>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1992" name="Blood" volume="80" first="937" last="941">
<title>Identification of a point mutation in factor XIII A subunit deficiency.</title>
<authorList>
<person name="Board P."/>
<person name="Coggan M."/>
<person name="Miloszewski K."/>
</authorList>
<dbReference type="PubMed" id="1353995"/>
</citation>
<scope>VARIANT FA13AD HIS-682</scope>
<scope>INVOLVEMENT IN FA13AD</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1998" name="Blood" volume="92" first="2766" last="2770">
<title>The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.</title>
<authorList>
<person name="Kangsadalampai S."/>
<person name="Board P.G."/>
</authorList>
<dbReference type="PubMed" id="9763561"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT LEU-35</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANTS LEU-35; ILE-551; LEU-565; GLN-589; ILE-651 AND GLU-652</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Haematologica" volume="95" first="956" last="962">
<title>Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.</title>
<authorList>
<person name="Ivaskevicius V."/>
<person name="Biswas A."/>
<person name="Bevans C."/>
<person name="Schroeder V."/>
<person name="Kohler H.P."/>
<person name="Rott H."/>
<person name="Halimeh S."/>
<person name="Petrides P.E."/>
<person name="Lenk H."/>
<person name="Krause M."/>
<person name="Miterski B."/>
<person name="Harbrecht U."/>
<person name="Oldenburg J."/>
</authorList>
<dbReference type="PubMed" id="20179087"/>
<dbReference type="DOI" id="10.3324/haematol.2009.017210"/>
</citation>
<scope>VARIANTS FA13AD CYS-168; ARG-290; GLN-541; SER-593; HIS-612 AND GLY-669</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Ann. Hematol." volume="93" first="1665" last="1676">
<title>Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function.</title>
<authorList>
<person name="Biswas A."/>
<person name="Ivaskevicius V."/>
<person name="Thomas A."/>
<person name="Varvenne M."/>
<person name="Brand B."/>
<person name="Rott H."/>
<person name="Haussels I."/>
<person name="Ruehl H."/>
<person name="Scholz U."/>
<person name="Klamroth R."/>
<person name="Oldenburg J."/>
</authorList>
<dbReference type="PubMed" id="24889649"/>
<dbReference type="DOI" id="10.1007/s00277-014-2102-4"/>
</citation>
<scope>VARIANTS FA13AD LEU-167; GLN-172; TYR-343; ARG-416; PRO-530; LYS-602; GLN-704 AND GLY-716</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Haemophilia" volume="20" first="255" last="262">
<title>Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.</title>
<authorList>
<person name="Souri M."/>
<person name="Biswas A."/>
<person name="Misawa M."/>
<person name="Omura H."/>
<person name="Ichinose A."/>
</authorList>
<dbReference type="PubMed" id="24286209"/>
<dbReference type="DOI" id="10.1111/hae.12298"/>
</citation>
<scope>VARIANT FA13AD VAL-274</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Haemophilia" volume="20" first="568" last="574">
<title>Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.</title>
<authorList>
<person name="Borhany M."/>
<person name="Handrkova H."/>
<person name="Cairo A."/>
<person name="Schroeder V."/>
<person name="Fatima N."/>
<person name="Naz A."/>
<person name="Amanat S."/>
<person name="Shamsi T."/>
<person name="Peyvandi F."/>
<person name="Kohler H.P."/>
</authorList>
<dbReference type="PubMed" id="24329762"/>
<dbReference type="DOI" id="10.1111/hae.12340"/>
</citation>
<scope>VARIANTS FA13AD ASP-347; ARG-376 AND LEU-414</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Hum. Mutat." volume="37" first="1030" last="1041">
<title>Coagulation factor XIIIA subunit missense mutations affect structure and function at the various steps of factor XIII action.</title>
<authorList>
<person name="Thomas A."/>
<person name="Biswas A."/>
<person name="Dodt J."/>
<person name="Philippou H."/>
<person name="Hethershaw E."/>
<person name="Ensikat H.J."/>
<person name="Ivaskevicius V."/>
<person name="Oldenburg J."/>
</authorList>
<dbReference type="PubMed" id="27363989"/>
<dbReference type="DOI" id="10.1002/humu.23041"/>
</citation>
<scope>CHARACTERIZATION VARIANTS FA13AD GLN-38; LEU-167; CYS-168; GLN-172; ARG-290; TYR-343; ARG-416; PRO-530; GLN-541; SER-593; LYS-602; HIS-612; GLY-669; GLN-704 AND GLY-716</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="18">Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.</text>
</comment>
<comment type="catalytic activity">
<text evidence="7 18">A protein-L-glutamine + a protein-L-lysine = a protein with an N(6)-(gamma-glutamyl)-L-lysine cross-link + NH(3).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="24">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<text evidence="24">Binds 1 Ca(2+) ion per subunit.</text>
</comment>
<comment type="subunit">
<text evidence="17 21">Tetramer of two A chains (F13A1) and two B (F13B) chains.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Secreted</location>
</subcellularLocation>
<text>Secreted into the blood plasma. Cytoplasmic in most tissues, but also secreted in the blood plasma.</text>
</comment>
<comment type="PTM">
<text>The activation peptide is released by thrombin.</text>
</comment>
<comment type="polymorphism">
<text evidence="27">There are four main allelic forms of this protein; F13A*1A, F13A*1B, F13A*2A and F13A*2B. In addition two other intermediate forms (F13A*(2)A and F13A*(2)B) seem to exist. The sequence shown is that of F13A*(2)B.</text>
</comment>
<comment type="disease" evidence="9 13 14 15 16 18">
<disease id="DI-01543">
<name>Factor XIII subunit A deficiency</name>
<acronym>FA13AD</acronym>
<description>An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.</description>
<dbReference type="MIM" id="613225"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the transglutaminase superfamily. Transglutaminase family.</text>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA52489" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92089" version="1"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/f13a1/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=F13A1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Factor_XIII"/>
<text>Factor XIII entry</text>
</comment>
<dbReference type="EC" id="2.3.2.13" evidence="18"/>
<dbReference type="EMBL" id="M14539">
<property type="protein sequence ID" value="AAA52489.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M14354">
<property type="protein sequence ID" value="AAA52488.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M22001">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21987">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21988">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21989">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21990">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21991">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21992">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21993">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21995">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21996">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21997">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21998">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21999">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22000">
<property type="protein sequence ID" value="AAA52415.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208852">
<property type="protein sequence ID" value="BAD92089.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF418272">
<property type="protein sequence ID" value="AAL12161.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL157775">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL391420">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133326">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027963">
<property type="protein sequence ID" value="AAH27963.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4496.1"/>
<dbReference type="PIR" id="A35583">
<property type="entry name" value="EKHUX"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000120.2">
<property type="nucleotide sequence ID" value="NM_000129.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.335513"/>
<dbReference type="PDB" id="1EVU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1EX0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1F13">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1FIE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1GGT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1GGU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1GGY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="1QRK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDB" id="4KTY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=2-732"/>
</dbReference>
<dbReference type="PDBsum" id="1EVU"/>
<dbReference type="PDBsum" id="1EX0"/>
<dbReference type="PDBsum" id="1F13"/>
<dbReference type="PDBsum" id="1FIE"/>
<dbReference type="PDBsum" id="1GGT"/>
<dbReference type="PDBsum" id="1GGU"/>
<dbReference type="PDBsum" id="1GGY"/>
<dbReference type="PDBsum" id="1QRK"/>
<dbReference type="PDBsum" id="4KTY"/>
<dbReference type="ProteinModelPortal" id="P00488"/>
<dbReference type="SMR" id="P00488"/>
<dbReference type="BioGrid" id="108460">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="DIP" id="DIP-377N"/>
<dbReference type="IntAct" id="P00488">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="MINT" id="MINT-7966415"/>
<dbReference type="STRING" id="9606.ENSP00000264870"/>
<dbReference type="BindingDB" id="P00488"/>
<dbReference type="ChEMBL" id="CHEMBL4530"/>
<dbReference type="DrugBank" id="DB00130">
<property type="generic name" value="L-Glutamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02340">
<property type="generic name" value="N-Acetyl-Serine"/>
</dbReference>
<dbReference type="iPTMnet" id="P00488"/>
<dbReference type="PhosphoSitePlus" id="P00488"/>
<dbReference type="BioMuta" id="F13A1"/>
<dbReference type="DMDM" id="119720"/>
<dbReference type="OGP" id="P00488"/>
<dbReference type="EPD" id="P00488"/>
<dbReference type="MaxQB" id="P00488"/>
<dbReference type="PaxDb" id="P00488"/>
<dbReference type="PeptideAtlas" id="P00488"/>
<dbReference type="PRIDE" id="P00488"/>
<dbReference type="TopDownProteomics" id="P00488"/>
<dbReference type="DNASU" id="2162"/>
<dbReference type="Ensembl" id="ENST00000264870">
<property type="protein sequence ID" value="ENSP00000264870"/>
<property type="gene ID" value="ENSG00000124491"/>
</dbReference>
<dbReference type="GeneID" id="2162"/>
<dbReference type="KEGG" id="hsa:2162"/>
<dbReference type="UCSC" id="uc003mwv.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2162"/>
<dbReference type="DisGeNET" id="2162"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000124491.15"/>
<dbReference type="GeneCards" id="F13A1"/>
<dbReference type="HGNC" id="HGNC:3531">
<property type="gene designation" value="F13A1"/>
</dbReference>
<dbReference type="HPA" id="CAB002155"/>
<dbReference type="HPA" id="HPA001804"/>
<dbReference type="MalaCards" id="F13A1"/>
<dbReference type="MIM" id="134570">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="613225">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00488"/>
<dbReference type="Orphanet" id="331">
<property type="disease" value="Congenital factor XIII deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA162"/>
<dbReference type="eggNOG" id="ENOG410IFMV">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQEZ">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000231695"/>
<dbReference type="HOVERGEN" id="HBG004342"/>
<dbReference type="InParanoid" id="P00488"/>
<dbReference type="KO" id="K03917"/>
<dbReference type="OrthoDB" id="EOG091G030K"/>
<dbReference type="PhylomeDB" id="P00488"/>
<dbReference type="TreeFam" id="TF324278"/>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-140875">
<property type="pathway name" value="Common Pathway of Fibrin Clot Formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and 13 signaling"/>
</dbReference>
<dbReference type="ChiTaRS" id="F13A1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00488"/>
<dbReference type="GeneWiki" id="Coagulation_factor_XIII,_A1_polypeptide"/>
<dbReference type="GenomeRNAi" id="2162"/>
<dbReference type="PMAP-CutDB" id="P00488"/>
<dbReference type="PRO" id="PR:P00488"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000124491"/>
<dbReference type="CleanEx" id="HS_F13A1"/>
<dbReference type="ExpressionAtlas" id="P00488">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00488">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031093">
<property type="term" value="C:platelet alpha granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003810">
<property type="term" value="F:protein-glutamine gamma-glutamyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072378">
<property type="term" value="P:blood coagulation, fibrin clot formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018149">
<property type="term" value="P:peptide cross-linking"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.260.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034810">
<property type="entry name" value="Factor_XIII_A"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002931">
<property type="entry name" value="Transglutaminase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036985">
<property type="entry name" value="Transglutaminase-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR023608">
<property type="entry name" value="Transglutaminase_animal"/>
</dbReference>
<dbReference type="InterPro" id="IPR013808">
<property type="entry name" value="Transglutaminase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008958">
<property type="entry name" value="Transglutaminase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR036238">
<property type="entry name" value="Transglutaminase_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001102">
<property type="entry name" value="Transglutaminase_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11590:SF42">
<property type="entry name" value="PTHR11590:SF42"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00927">
<property type="entry name" value="Transglut_C"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01841">
<property type="entry name" value="Transglut_core"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00868">
<property type="entry name" value="Transglut_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000459">
<property type="entry name" value="TGM_EBP42"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00460">
<property type="entry name" value="TGc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49309">
<property type="entry name" value="SSF49309"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00547">
<property type="entry name" value="TRANSGLUTAMINASES"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0094">Blood coagulation</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0356">Hemostasis</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0865">Zymogen</keyword>
<feature type="initiator methionine" description="Removed" evidence="28 29">
<location>
<position position="1"/>
</location>
</feature>
<feature type="propeptide" description="Activation peptide" id="PRO_0000033646">
<location>
<begin position="2"/>
<end position="38"/>
</location>
</feature>
<feature type="chain" description="Coagulation factor XIII A chain" id="PRO_0000033647">
<location>
<begin position="39"/>
<end position="732"/>
</location>
</feature>
<feature type="active site" evidence="22">
<location>
<position position="315"/>
</location>
</feature>
<feature type="active site" evidence="22">
<location>
<position position="374"/>
</location>
</feature>
<feature type="active site" evidence="22">
<location>
<position position="397"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="24">
<location>
<position position="437"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="24">
<location>
<position position="439"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="24">
<location>
<position position="486"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="24">
<location>
<position position="491"/>
</location>
</feature>
<feature type="site" description="Cleavage; by thrombin; to produce active factor XIII-A">
<location>
<begin position="38"/>
<end position="39"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="28">
<location>
<position position="2"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="614"/>
</location>
</feature>
<feature type="sequence variant" description="Higher specific activity; dbSNP:rs5985." id="VAR_013927" evidence="8 23 26">
<original>V</original>
<variation>L</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; no effect on fibrin alpha chain and gamma chain cross-linking activity; decreased clot fiber thickness; dbSNP:rs759324596." id="VAR_077619" evidence="18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020910" evidence="26">
<original>V</original>
<variation>I</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; no effect on intracellular protein abundance; no effect on protein-glutamine gamma-glutamyltransferase activity; no effect on alpha-2-antiplasmin to fibrin cross-linking activity; loss of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074280" evidence="16 18">
<original>P</original>
<variation>L</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; decreased protein-glutamine gamma-glutamyltransferase activity; no effect on alpha-2-antiplasmin to fibrin cross-linking activity; loss of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_077620" evidence="13 18">
<original>Y</original>
<variation>C</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; decreased rate of fibrin gamma chain cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074281" evidence="16 18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3024477." id="VAR_020911" evidence="26">
<original>Y</original>
<variation>F</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD." id="VAR_074282" evidence="14">
<original>G</original>
<variation>V</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; loss of alpha-2-antiplasmin to fibrin cross-linking activity; loss of fibrin gamma chain cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_077621" evidence="13 18">
<original>P</original>
<variation>R</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; loss of fibrin gamma chain cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074283" evidence="16 18">
<original>H</original>
<variation>Y</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; unknown pathological significance." id="VAR_074284" evidence="15">
<original>A</original>
<variation>D</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; unknown pathological significance." id="VAR_074285" evidence="15">
<original>W</original>
<variation>R</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; unknown pathological significance." id="VAR_074286" evidence="15">
<original>S</original>
<variation>L</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; no effect on intracellular protein abundance; no effect on protein-glutamine gamma-glutamyltransferase activity; no effect on alpha-2-antiplasmin to fibrin cross-linking activity; no effect on fibrin alpha chain and gamma chain cross-linking activity; decreased clot fiber thickness." id="VAR_074287" evidence="16 18">
<original>Q</original>
<variation>R</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; loss of fibrin gamma chain cross-linking activity; decreased clot fiber thickness." id="VAR_074288" evidence="16 18">
<original>L</original>
<variation>P</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; no effect on protein-glutamine gamma-glutamyltransferase activity; no effect on alpha-2-antiplasmin to fibrin cross-linking activity; no effect on fibrin alpha chain and gamma chain cross-linking activity; decreased clot fiber thickness." id="VAR_077622" evidence="13 18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5984." id="VAR_013928" evidence="8">
<original>T</original>
<variation>I</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence variant" description="In allele F13A*1A, allele F13A*2A and allele F13*(2)A; dbSNP:rs5982." id="VAR_007471" evidence="8 19 26">
<original>P</original>
<variation>L</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5983." id="VAR_013929" evidence="8">
<original>L</original>
<variation>Q</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; no effect on intracellular protein abundance; increased protein-glutamine gamma-glutamyltransferase activity; no effect on alpha-2-antiplasmin to fibrin cross-linking activity; no effect on fibrin alpha chain and gamma chain cross-linking activity; decreased clot fiber thickness." id="VAR_077623" evidence="13 18">
<original>G</original>
<variation>S</variation>
<location>
<position position="593"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; loss of alpha-2-antiplasmin to fibrin cross-linking activity; decreased rate of fibrin gamma chain cross-linking activity; loss of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074289" evidence="16 18">
<original>Q</original>
<variation>K</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; decreased protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; no effect on fibrin alpha chain and gamma chain cross-linking activity; decreased clot fiber thickness." id="VAR_077624" evidence="13 18">
<original>R</original>
<variation>H</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17852475." id="VAR_060545" evidence="11">
<original>T</original>
<variation>I</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence variant" description="In allele F13A*2A and allele F13A*2B; dbSNP:rs5987." id="VAR_007472" evidence="8 20 26">
<original>V</original>
<variation>I</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="sequence variant" description="In allele F13A*1A and allele F13A*1B; dbSNP:rs5988." id="VAR_007473" evidence="8 10 11 25 26">
<original>Q</original>
<variation>E</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; decreased intracellular protein abundance; decreased protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_077625" evidence="13 18">
<original>D</original>
<variation>G</variation>
<location>
<position position="669"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD." id="VAR_007474" evidence="9">
<original>R</original>
<variation>H</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074290" evidence="16 18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In FA13AD; mild; decreased intracellular protein abundance; loss of protein-glutamine gamma-glutamyltransferase activity; decreased alpha-2-antiplasmin to fibrin cross-linking activity; decreased rate of fibrin gamma chain cross-linking activity; decreased rate of fibrin alpha chain cross-linking activity; decreased clot fiber thickness." id="VAR_074291" evidence="16 18">
<original>R</original>
<variation>G</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AA sequence." ref="9" evidence="27">
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52488." ref="1" evidence="27">
<original>F</original>
<variation>L</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="29"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="42"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="48"/>
<end position="52"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="60"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="68"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="74"/>
<end position="78"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="81"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="100"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="116"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="132"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="142"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="156"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="169"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="181"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="199"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="210"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="220"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="235"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="256"/>
<end position="266"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="275"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="297"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="310"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="315"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="333"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="345"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="369"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="392"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="406"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="415"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="425"/>
<end position="428"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="429"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="439"/>
<end position="445"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="451"/>
<end position="461"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="464"/>
<end position="468"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="470"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="475"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="479"/>
<end position="482"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="489"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="519"/>
<end position="527"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="534"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="544"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="548"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="565"/>
<end position="578"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="580"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="592"/>
<end position="595"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="596"/>
<end position="598"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="604"/>
<end position="613"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="614"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="618"/>
<end position="626"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="633"/>
<end position="639"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="647"/>
<end position="654"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="657"/>
<end position="659"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="661"/>
<end position="670"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="671"/>
<end position="673"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="674"/>
<end position="684"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="689"/>
<end position="696"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="702"/>
<end position="711"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="713"/>
<end position="727"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EVU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EX0"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FIE"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GGU"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GGY"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KTY"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10024"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1353995"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14574404"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20179087"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24286209"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24329762"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24889649"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26247044"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27363989"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2901091"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3026437"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="4405643"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7913750"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9763561"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9988734"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="2877456"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="4811064"/>
</source>
</evidence>
<sequence length="732" mass="83267" checksum="51A83A9B8B1370D4" modified="2007-01-23" version="4" precursor="true">
MSETSRTAFGGRRAVPPNNSNAAEDDLPTVELQGVVPRGVNLQEFLNVTSVHLFKERWDT
NKVDHHTDKYENNKLIVRRGQSFYVQIDFSRPYDPRRDLFRVEYVIGRYPQENKGTYIPV
PIVSELQSGKWGAKIVMREDRSVRLSIQSSPKCIVGKFRMYVAVWTPYGVLRTSRNPETD
TYILFNPWCEDDAVYLDNEKEREEYVLNDIGVIFYGEVNDIKTRSWSYGQFEDGILDTCL
YVMDRAQMDLSGRGNPIKVSRVGSAMVNAKDDEGVLVGSWDNIYAYGVPPSAWTGSVDIL
LEYRSSENPVRYGQCWVFAGVFNTFLRCLGIPARIVTNYFSAHDNDANLQMDIFLEEDGN
VNSKLTKDSVWNYHCWNEAWMTRPDLPVGFGGWQAVDSTPQENSDGMYRCGPASVQAIKH
GHVCFQFDAPFVFAEVNSDLIYITAKKDGTHVVENVDATHIGKLIVTKQIGGDGMMDITD
TYKFQEGQEEERLALETALMYGAKKPLNTEGVMKSRSNVDMDFEVENAVLGKDFKLSITF
RNNSHNRYTITAYLSANITFYTGVPKAEFKKETFDVTLEPLSFKKEAVLIQAGEYMGQLL
EQASLHFFVTARINETRDVLAKQKSTVLTIPEIIIKVRGTQVVGSDMTVTVQFTNPLKET
LRNVWVHLDGPGVTRPMKKMFREIRPNSTVQWEEVCRPWVSGHRKLIASMSSDSLRHVYG
ELDVQIQRRPSM
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>